Shineco, Inc. Intends to Acquire Biotechnology Company to Jointly Develop Rapid-acting Antidepressant Natural Innovative Medicine

Stock Information for null

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About null

Shineco, Inc. Announces Nasdaq Ticker Symbol Change from "TYHT" to "SISI"
Shineco, Inc. Announces It's Unaware of Reason for Stock Volatility
Shineco, Inc. Announces Appointment of New CEO
Shineco, Inc. Proposes to Acquire 51% Equity Interests in Mayah Biological Holdings Limited
Shineco, Inc. Reports Fiscal Year 2020 Financial Results
Shineco Announces One-for-Nine Reverse Stock Split Effective August 17, 2020
Shineco, Inc. Announces CEO Change for Strategic Transformation
Shineco, Inc. Enters into a Letter of Intent to Acquire Controlling Interest in Changzhou Biowin Pharmaceutical Co., Ltd

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.